In addition, GM‐derived lipopolysaccharide (LPS) particles can cross the placenta via toll‐like receptors (TLR) 2 and TLR4, reach fetal tissues, activate inflammatory pathways leading to alterations in fetal development [74], and increase the risk of developing cardiovascular disease, such as arterial hypertension later in life [75]. This evidence concerns the gene TLR4 and cardiovascular disorder.